For LC1, one possible explanation for the marked up‐regulation of cell cycle–related pathways is that the proliferation of lymphocytes, especially CD8 T cells, is stimulated via antigen presentation by dendritic cells (DCs), thereby producing effector cells and enhancing cell immunity against tumour cells. Here, CD8A is linked to neoplasm.